Literature DB >> 33777712

Early Experiences in the Integration of Non-communicable Diseases into Emergency Primary Health Care, Beni Region, Democratic Republic of the Congo.

Ruwan Ratnayake1,2, Alison Wittcoff1, John Majaribu3, Jean-Pierre Nzweve3, Lambert Katembo3, Kambale Kasonia2,4, Adelard Kalima Nzanzu4,5, Lilian Kiapi6, Pascal Ngoy3.   

Abstract

Background: Health services in humanitarian crises increasingly integrate the management of non-communicable diseases into primary care. As there is little description of such programs, this case study aims to describe the initial implementation of non-communicable disease management within emergency primary care in the conflict-affected Beni Region of Democratic Republic of the Congo (DRC).
Objectives: We implemented and evaluated a primary care approach to hypertension and diabetes management to assess the feasibility of patient monitoring, early clinical and programmatic outcomes, and costs, after seven months of care.
Methods: We designed clinical and programmatic modules for diabetes and hypertension management for clinical officers and the use of patient cards and community health workers to improve adherence. We used cohort analysis (April to October 2018), time-trend analysis, semi-structured interviews, and costing to evaluate the program. Findings: Increases in consultations for hypertension (incidence rate ratio [IRR] 13.5, 95% CI 5.8-31.5, p < 0.00) and diabetes (IRR 3.6, 95% CI 1-12.9, p < 0.05) were demonstrated up to the onset of violence and an Ebola epidemic in August 2018. Of 833 patients, 67% were women of median age 56. Nearly all were hypertensives (88.7%) and newly diagnosed (95.9%). Treatment adherence, defined as attending ≥2 visits in the seven month period, was demonstrated by 45.4% of hypertension patients. Community health workers had contact with 3.2-3.8 patients per month. Respondents stated that diabetes care remained fragmented with insulin and laboratory testing located outside of primary care. Program and management costs were 115 USD per person per treatment course. Conclusions: In an active conflict setting, we demonstrated that non-communicable disease care can be well-organized through clinical training and cohort analysis, and adherence can be addressed using patient-held cards and monitoring by community health workers. Nearly all diagnoses were new, emphasizing the need to establish self-management. Insecurity reduced access for patients but care continued for a subset of patients during the Ebola epidemic. Copyright:
© 2021 The Author(s).

Entities:  

Year:  2021        PMID: 33777712      PMCID: PMC7977479          DOI: 10.5334/aogh.3019

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN: 2214-9996            Impact factor:   2.462


  26 in total

1.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.

Authors:  David R Whiting; Leonor Guariguata; Clara Weil; Jonathan Shaw
Journal:  Diabetes Res Clin Pract       Date:  2011-11-12       Impact factor: 5.602

2.  Mortality in the Democratic Republic of Congo: a nationwide survey.

Authors:  Benjamin Coghlan; Richard J Brennan; Pascal Ngoy; David Dofara; Brad Otto; Mark Clements; Tony Stewart
Journal:  Lancet       Date:  2006-01-07       Impact factor: 79.321

3.  Qualitative data analysis for health services research: developing taxonomy, themes, and theory.

Authors:  Elizabeth H Bradley; Leslie A Curry; Kelly J Devers
Journal:  Health Serv Res       Date:  2007-08       Impact factor: 3.402

Review 4.  Challenges associated with providing diabetes care in humanitarian settings.

Authors:  Philippa Boulle; Sylvia Kehlenbrink; James Smith; David Beran; Kiran Jobanputra
Journal:  Lancet Diabetes Endocrinol       Date:  2019-03-14       Impact factor: 32.069

5.  Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017.

Authors:  Hebe N Gouda; Fiona Charlson; Katherine Sorsdahl; Sanam Ahmadzada; Alize J Ferrari; Holly Erskine; Janni Leung; Damian Santamauro; Crick Lund; Leopold Ndemnge Aminde; Bongani M Mayosi; Andre Pascal Kengne; Meredith Harris; Tom Achoki; Charles S Wiysonge; Dan J Stein; Harvey Whiteford
Journal:  Lancet Glob Health       Date:  2019-10       Impact factor: 26.763

Review 6.  The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries.

Authors:  Sylvia Kehlenbrink; James Smith; Éimhín Ansbro; Daniela C Fuhr; Anson Cheung; Ruwan Ratnayake; Philippa Boulle; Kiran Jobanputra; Pablo Perel; Bayard Roberts
Journal:  Lancet Diabetes Endocrinol       Date:  2019-03-14       Impact factor: 32.069

7.  Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial.

Authors:  Dinesh Neupane; Craig S McLachlan; Shiva Raj Mishra; Michael Hecht Olsen; Henry B Perry; Arjun Karki; Per Kallestrup
Journal:  Lancet Glob Health       Date:  2018-01       Impact factor: 26.763

8.  The Ongoing Ebola Epidemic in the Democratic Republic of Congo, 2018-2019.

Authors:  Oly Ilunga Kalenga; Matshidiso Moeti; Annie Sparrow; Vinh-Kim Nguyen; Daniel Lucey; Tedros A Ghebreyesus
Journal:  N Engl J Med       Date:  2019-05-29       Impact factor: 91.245

9.  Diabetes care in a complex humanitarian emergency setting: a qualitative evaluation.

Authors:  Adrianna Murphy; Michel Biringanine; Bayard Roberts; Beverley Stringer; Pablo Perel; Kiran Jobanputra
Journal:  BMC Health Serv Res       Date:  2017-06-23       Impact factor: 2.655

10.  Evaluation of a training program of hypertension for accredited social health activists (ASHA) in rural India.

Authors:  Marwa Abdel-All; Amanda Gay Thrift; Michaela Riddell; Kavumpurathu Raman Thankappan Thankappan; Gomathyamma Krishnakurup Mini; Clara K Chow; Pallab Kumar Maulik; Ajay Mahal; Rama Guggilla; Kartik Kalyanram; Kamakshi Kartik; Oduru Suresh; Roger George Evans; Brian Oldenburg; Nihal Thomas; Rohina Joshi
Journal:  BMC Health Serv Res       Date:  2018-05-02       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.